Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Skycorp Solar Group Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Greenlight Re Announces Financial Results for Third Quarter and Nine Months Ended September 30, 2025
-
Upwork Reports Third Quarter 2025 Financial Results
-
Diversified Energy Announces Third Quarter Dividend
-
CAUT available to comment on post-secondary education and research in the federal budget
-
Bogota Financial Corp. Reports Results for the Three and Nine Months Ended September 30, 2025
-
Compass Diversified Announces Extension of Credit Agreement Forbearance
-
UFP Technologies Announces Strong Q3 2025 Results
-
Beta Bionics Announces Participation at Upcoming Investor Conferences
-
The Ensign Group Reports Third Quarter 2025 Results; Raises Annual Earnings and Revenue Guidance
-
Castle Biosciences Reports Third Quarter 2025 Results
-
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
-
Mobile Infrastructure Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
-
ThredUp Announces Third Quarter 2025 Results
-
Hudson Technologies Announces CEO Departure and Succession Plan
-
Eagle Bancorp, Inc. Announces Leadership Transition
-
Armada Hoffler Reports Third Quarter 2025 Results
-
Bitterroot Bio to Present Anti-CD47 Research at American Heart Association Annual Scientific Session 2025
-
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week
-
Reed’s Reports Third Quarter 2025 Results
-
Superior Group of Companies Reports Third Quarter 2025 Results
-
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Ormat Technologies Reports Third Quarter 2025 Financial Results
-
Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
-
Gaia Reports Third Quarter 2025 Results
-
TELA Bio Appoints William Plovanic to Board of Directors
-
James River Announces Third Quarter 2025 Results
-
Flux Power to Host Fiscal First Quarter 2026 Financial Results Conference Call on November 13, 2025
-
Glucotrack, Inc. Encourages Shareholders to Vote
-
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
-
ThredUp Announces Third Quarter 2025 Results
-
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
-
EverQuote Announces Third Quarter 2025 Financial Results
-
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
-
Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results
-
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
-
BBOT to Participate in the Jefferies Global Healthcare Conference in London
-
Mobile Infrastructure Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
-
Pyxis Oncology to Participate in Upcoming Investor Conferences
-
BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors
-
Regeneron Announces Investor Conference Presentations
-
InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer
-
Option Care Health to Participate in Upcoming Investor Conferences
-
Lakeland Fire + Safety Declares Cash Dividend for Fourth Quarter 2026
-
Nyxoah to Participate in the Stifel 2025 Healthcare Conference
-
Castle Biosciences Launches AdvanceAD-Tx™ to Help Guide Systemic Treatment Decision Making in Patients with Moderate-to-Severe Atopic Dermatitis
-
NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing
-
Navitas Semiconductor Announces Third Quarter 2025 Financial Results
